AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stanko, R. T.
Right arrow Articles by Wolf, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stanko, R. T.
Right arrow Articles by Wolf, R.
Agricola
Right arrow Articles by Stanko, R. T.
Right arrow Articles by Wolf, R.

American Journal of Clinical Nutrition, Vol 59, 423-427, Copyright © 1994 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Pyruvate supplementation of a low-cholesterol, low-fat diet: effects on plasma lipid concentrations and body composition in hyperlipidemic patients

RT Stanko, HR Reynolds, R Hoyson, JE Janosky and R Wolf
Department of Medicine, Montefiore University Hospital, Pittsburgh, PA 15213-2582.

The effects of the three-carbon compound pyruvate on plasma lipid concentrations and body composition were evaluated in hyperlipidemic patients consuming a low-cholesterol (165-180 mg), low-fat (22-24% of energy; 18-20% of energy as saturated fatty acid) diet (0.091-0.099 MJ.kg body wt-1 x d-1). After consuming the above diet for 4 wk, during which time plasma lipid concentrations decreased, 34 subjects were randomly assigned to receive either 22-44 g pyruvate (n = 17) or 18-35 g polyglucose (placebo, Polycose, n = 17), iso-energetically substituted for a portion of carbohydrate energy for 6 wk. Despite greater weight and fat losses with pyruvate (P < 0.05), plasma concentrations of cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride were not different between the two groups of subjects. We conclude that subsequent to diet-induced reduction in plasma lipid concentrations, pyruvate supplementation of a low-cholesterol, low-fat diet providing 6.7-7.6 MJ/d for 6 wk has no effect on plasma lipid concentrations but enhances body weight and fat losses.


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Wilson, Q. Yang, J. D. Szustakowski, P. S. Gullicksen, and R. Halse
Pyruvate induces mitochondrial biogenesis by a PGC-1 {alpha}-independent mechanism
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1599 - C1605.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. H Pittler and E. Ernst
Dietary supplements for body-weight reduction: a systematic review
Am. J. Clinical Nutrition, April 1, 2004; 79(4): 529 - 536.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by The American Society for Nutrition